raf 1 Search Results


93
TargetMol redocking original ligand
Figure 1. Crystal structure <t>of</t> <t>DENV-NS5</t> (PDB ID: 4V0R) and crystal structure of DENV-NS5 RdRp domain in complex with Compound 27 (PDB ID: 5K5M).
Redocking Original Ligand, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/RAF1+Protein%2C+Human%2C+Recombinant/pm39936614-35-8-62
Average 93 stars, based on 1 article reviews
redocking original ligand - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Proteintech raf1
Figure 1. Crystal structure <t>of</t> <t>DENV-NS5</t> (PDB ID: 4V0R) and crystal structure of DENV-NS5 RdRp domain in complex with Compound 27 (PDB ID: 5K5M).
Raf1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/RAF1+Antibody/ppr0404470-76-16-21
Average 95 stars, based on 1 article reviews
raf1 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology b raf
Figure 1. Crystal structure <t>of</t> <t>DENV-NS5</t> (PDB ID: 4V0R) and crystal structure of DENV-NS5 RdRp domain in complex with Compound 27 (PDB ID: 5K5M).
B Raf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/Raf-1+Antibody/10__1074_slash_jbc__m305797200-95-20-23
Average 94 stars, based on 1 article reviews
b raf - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology anti raf 1
Figure 1. Crystal structure <t>of</t> <t>DENV-NS5</t> (PDB ID: 4V0R) and crystal structure of DENV-NS5 RdRp domain in complex with Compound 27 (PDB ID: 5K5M).
Anti Raf 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/Raf-1/10__1021_slash_jm401552y-470-27-32
Average 94 stars, based on 1 article reviews
anti raf 1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Fortis Life Sciences a301 519a
Figure 1. Crystal structure <t>of</t> <t>DENV-NS5</t> (PDB ID: 4V0R) and crystal structure of DENV-NS5 RdRp domain in complex with Compound 27 (PDB ID: 5K5M).
A301 519a, supplied by Fortis Life Sciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/RAF1%2Fc-RAF+Antibody/pm35122079-377-31-29
Average 93 stars, based on 1 article reviews
a301 519a - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
OriGene raf1 human recombinant protein
(A) A two-week growth CRISPR screen of 150 common Ras-proximal proteins in diploid primary human melanocytes (MC) and 5 MT Ras cell lines. Left heatmap negative selection FDR values (FDR ≤ 0.18) in each cell type by the MAGeCK algorithm (Li et al., 2014). The right heatmap relative enrichment MT vs WT Ras in mass spectrometry data for each Ras isoform; new proteins (red), known proteins (*). Ranked by combined FDR and log2(PSM MT/WT Ras) score. (B) Common Ras-proximal interacting protein-protein network based on candidates with ≥1 database interaction with another common interactor. Large squares are novel and small squares are known interactors. (C) PLA in MT NRAS MM415 melanoma cells with endogenous mTOR and Pan-Ras or Ras:GTP; interaction (red), nuclei (blue). Scale bar, 20 μm. (D) Quantification of PLA analysis in (C). n=8-10 fields/condition. (E) Western blot of HA co-immunoprecipitation of empty vector (EV), FLAG-HA-6xHIS tagged NRASWT or FHH: NRASQ61K with endogenous mTOR, p110α and <t>Raf1</t> in wild-type RAS CHL-1 cells. (F) Quantification of HA co-IP experiments as in (E). Values are normalized to HA pulldown signal and relative to NRASWT signal, n= 6 (Wilcoxon Signed Rank Test). (G) PLA in genotyped human colorectal adenocarcinomas with endogenous Pan-Ras and mTOR. Scale bar, 20 μm. (H) Quantification of PLA analysis in (G). Each dot represents median signal per patient. n=5 patients/genotype group, ≥7 images analyzed per patient (Mann-Whitney U Test). (I) Microscale thermophoresis with labeled FHH:Raf1RBD (18.2nM) with a titration series of GDP or GTPγs-loaded Ras. The binding curve is negative as the MST signal of the complex is lower than that of Raf1RBD alone. MST-on time of 15s, n = 3 independent replicates. (J) Microscale thermophoresis with labeled FHH:mTORKinaseDomain and FHH:mTORHEAT (23.4nM) with a titration series of GDP or GTPγs-loaded Ras. MST-on time of 2.5s, n ≥ 3 independent replicates. MST is mean ± SD. All other data mean ± SEM; *p< 0.05. See also Figures S3 and S4, Tables S2–4.
Raf1 Human Recombinant Protein, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/RAF1+(NM_002880)+Human+Recombinant+Protein/pmc06386588-74-0-5
Average 90 stars, based on 1 article reviews
raf1 human recombinant protein - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

92
Addgene inc 1 149 plasmid
(A) A two-week growth CRISPR screen of 150 common Ras-proximal proteins in diploid primary human melanocytes (MC) and 5 MT Ras cell lines. Left heatmap negative selection FDR values (FDR ≤ 0.18) in each cell type by the MAGeCK algorithm (Li et al., 2014). The right heatmap relative enrichment MT vs WT Ras in mass spectrometry data for each Ras isoform; new proteins (red), known proteins (*). Ranked by combined FDR and log2(PSM MT/WT Ras) score. (B) Common Ras-proximal interacting protein-protein network based on candidates with ≥1 database interaction with another common interactor. Large squares are novel and small squares are known interactors. (C) PLA in MT NRAS MM415 melanoma cells with endogenous mTOR and Pan-Ras or Ras:GTP; interaction (red), nuclei (blue). Scale bar, 20 μm. (D) Quantification of PLA analysis in (C). n=8-10 fields/condition. (E) Western blot of HA co-immunoprecipitation of empty vector (EV), FLAG-HA-6xHIS tagged NRASWT or FHH: NRASQ61K with endogenous mTOR, p110α and <t>Raf1</t> in wild-type RAS CHL-1 cells. (F) Quantification of HA co-IP experiments as in (E). Values are normalized to HA pulldown signal and relative to NRASWT signal, n= 6 (Wilcoxon Signed Rank Test). (G) PLA in genotyped human colorectal adenocarcinomas with endogenous Pan-Ras and mTOR. Scale bar, 20 μm. (H) Quantification of PLA analysis in (G). Each dot represents median signal per patient. n=5 patients/genotype group, ≥7 images analyzed per patient (Mann-Whitney U Test). (I) Microscale thermophoresis with labeled FHH:Raf1RBD (18.2nM) with a titration series of GDP or GTPγs-loaded Ras. The binding curve is negative as the MST signal of the complex is lower than that of Raf1RBD alone. MST-on time of 15s, n = 3 independent replicates. (J) Microscale thermophoresis with labeled FHH:mTORKinaseDomain and FHH:mTORHEAT (23.4nM) with a titration series of GDP or GTPγs-loaded Ras. MST-on time of 2.5s, n ≥ 3 independent replicates. MST is mean ± SD. All other data mean ± SEM; *p< 0.05. See also Figures S3 and S4, Tables S2–4.
1 149 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/Raf-1+GST+RBD+1-149+(Plasmid+%2313338)/pm32605999-69-5-11
Average 92 stars, based on 1 article reviews
1 149 plasmid - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Addgene inc pa sensor
(A) A two-week growth CRISPR screen of 150 common Ras-proximal proteins in diploid primary human melanocytes (MC) and 5 MT Ras cell lines. Left heatmap negative selection FDR values (FDR ≤ 0.18) in each cell type by the MAGeCK algorithm (Li et al., 2014). The right heatmap relative enrichment MT vs WT Ras in mass spectrometry data for each Ras isoform; new proteins (red), known proteins (*). Ranked by combined FDR and log2(PSM MT/WT Ras) score. (B) Common Ras-proximal interacting protein-protein network based on candidates with ≥1 database interaction with another common interactor. Large squares are novel and small squares are known interactors. (C) PLA in MT NRAS MM415 melanoma cells with endogenous mTOR and Pan-Ras or Ras:GTP; interaction (red), nuclei (blue). Scale bar, 20 μm. (D) Quantification of PLA analysis in (C). n=8-10 fields/condition. (E) Western blot of HA co-immunoprecipitation of empty vector (EV), FLAG-HA-6xHIS tagged NRASWT or FHH: NRASQ61K with endogenous mTOR, p110α and <t>Raf1</t> in wild-type RAS CHL-1 cells. (F) Quantification of HA co-IP experiments as in (E). Values are normalized to HA pulldown signal and relative to NRASWT signal, n= 6 (Wilcoxon Signed Rank Test). (G) PLA in genotyped human colorectal adenocarcinomas with endogenous Pan-Ras and mTOR. Scale bar, 20 μm. (H) Quantification of PLA analysis in (G). Each dot represents median signal per patient. n=5 patients/genotype group, ≥7 images analyzed per patient (Mann-Whitney U Test). (I) Microscale thermophoresis with labeled FHH:Raf1RBD (18.2nM) with a titration series of GDP or GTPγs-loaded Ras. The binding curve is negative as the MST signal of the complex is lower than that of Raf1RBD alone. MST-on time of 15s, n = 3 independent replicates. (J) Microscale thermophoresis with labeled FHH:mTORKinaseDomain and FHH:mTORHEAT (23.4nM) with a titration series of GDP or GTPγs-loaded Ras. MST-on time of 2.5s, n ≥ 3 independent replicates. MST is mean ± SD. All other data mean ± SEM; *p< 0.05. See also Figures S3 and S4, Tables S2–4.
Pa Sensor, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/pDONR223-RAF1+(Plasmid+%2323832)/ppr0174960-69-27-33
Average 93 stars, based on 1 article reviews
pa sensor - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

91
Addgene inc gst thr raf1 rbd
a Nucleotide exchange assay shows 3 Affimers, K3 (green triangles), K6 (turquoise triangles), and K37 (yellow triangles), inhibit SOS1-mediated nucleotide exchange, whilst K19 (orange diamonds) and K68 (magenta triangles) show inhibition of intrinsic nucleotide exchange and K69 (purple hexagons) and K91 (navy stars) do not inhibit nucleotide exchange at 10 µM. KRAS alone is shown as black squares and in the presence of SOS1 cat as red circles. b Affimers K3, K6, and K37 demonstrate dose-response inhibition of KRAS WT nucleotide exchange (Data fitted to the Hill Model ([Affimer] vs. response (three parameters)), n = 3 independent experiments for K3 and K6 and n = 5 for K37). c Immunoprecipitation of KRAS with <t>GST-RAF-RBD</t> is inhibited by the RAS-binding Affimers, K3, K6, and K37 compared to control Affimer (Variable regions of AAAA and AAE) which does not differ from the no Affimer (PBS). GST alone does not pull down RAS (Quantification using ImageQuantTL; n = 3 independent experiments). d A representative Western blot of the pull-down experiment from c . Data are mean ± SEM, One-way ANOVA with Dunnett’s post-hoc test * p = 0.0307 K6, p = 0.0439 K37, *** p = 0.0002 GST, **** p < 0.0001 K3. SOScat catalytic domain of SOS1 (Son of Sevenless). Con. Control Affimer, RBD RAS Binding Domain, IP immunoprecipitation, GST Glutathione-S-Transferase.
Gst Thr Raf1 Rbd, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/GST-thr-RAF1-RBD+(Plasmid+%2386033)/pmc08245420-250-0-9
Average 91 stars, based on 1 article reviews
gst thr raf1 rbd - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

93
Proteintech p braf
a Nucleotide exchange assay shows 3 Affimers, K3 (green triangles), K6 (turquoise triangles), and K37 (yellow triangles), inhibit SOS1-mediated nucleotide exchange, whilst K19 (orange diamonds) and K68 (magenta triangles) show inhibition of intrinsic nucleotide exchange and K69 (purple hexagons) and K91 (navy stars) do not inhibit nucleotide exchange at 10 µM. KRAS alone is shown as black squares and in the presence of SOS1 cat as red circles. b Affimers K3, K6, and K37 demonstrate dose-response inhibition of KRAS WT nucleotide exchange (Data fitted to the Hill Model ([Affimer] vs. response (three parameters)), n = 3 independent experiments for K3 and K6 and n = 5 for K37). c Immunoprecipitation of KRAS with <t>GST-RAF-RBD</t> is inhibited by the RAS-binding Affimers, K3, K6, and K37 compared to control Affimer (Variable regions of AAAA and AAE) which does not differ from the no Affimer (PBS). GST alone does not pull down RAS (Quantification using ImageQuantTL; n = 3 independent experiments). d A representative Western blot of the pull-down experiment from c . Data are mean ± SEM, One-way ANOVA with Dunnett’s post-hoc test * p = 0.0307 K6, p = 0.0439 K37, *** p = 0.0002 GST, **** p < 0.0001 K3. SOScat catalytic domain of SOS1 (Son of Sevenless). Con. Control Affimer, RBD RAS Binding Domain, IP immunoprecipitation, GST Glutathione-S-Transferase.
P Braf, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/BRAF+Antibody/pmc06396142-8-14-21
Average 93 stars, based on 1 article reviews
p braf - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology sirna targeting c raf
a Nucleotide exchange assay shows 3 Affimers, K3 (green triangles), K6 (turquoise triangles), and K37 (yellow triangles), inhibit SOS1-mediated nucleotide exchange, whilst K19 (orange diamonds) and K68 (magenta triangles) show inhibition of intrinsic nucleotide exchange and K69 (purple hexagons) and K91 (navy stars) do not inhibit nucleotide exchange at 10 µM. KRAS alone is shown as black squares and in the presence of SOS1 cat as red circles. b Affimers K3, K6, and K37 demonstrate dose-response inhibition of KRAS WT nucleotide exchange (Data fitted to the Hill Model ([Affimer] vs. response (three parameters)), n = 3 independent experiments for K3 and K6 and n = 5 for K37). c Immunoprecipitation of KRAS with <t>GST-RAF-RBD</t> is inhibited by the RAS-binding Affimers, K3, K6, and K37 compared to control Affimer (Variable regions of AAAA and AAE) which does not differ from the no Affimer (PBS). GST alone does not pull down RAS (Quantification using ImageQuantTL; n = 3 independent experiments). d A representative Western blot of the pull-down experiment from c . Data are mean ± SEM, One-way ANOVA with Dunnett’s post-hoc test * p = 0.0307 K6, p = 0.0439 K37, *** p = 0.0002 GST, **** p < 0.0001 K3. SOScat catalytic domain of SOS1 (Son of Sevenless). Con. Control Affimer, RBD RAS Binding Domain, IP immunoprecipitation, GST Glutathione-S-Transferase.
Sirna Targeting C Raf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/Raf-1+siRNA/pmc08983457-143-68-83
Average 93 stars, based on 1 article reviews
sirna targeting c raf - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti p raf 1
a Nucleotide exchange assay shows 3 Affimers, K3 (green triangles), K6 (turquoise triangles), and K37 (yellow triangles), inhibit SOS1-mediated nucleotide exchange, whilst K19 (orange diamonds) and K68 (magenta triangles) show inhibition of intrinsic nucleotide exchange and K69 (purple hexagons) and K91 (navy stars) do not inhibit nucleotide exchange at 10 µM. KRAS alone is shown as black squares and in the presence of SOS1 cat as red circles. b Affimers K3, K6, and K37 demonstrate dose-response inhibition of KRAS WT nucleotide exchange (Data fitted to the Hill Model ([Affimer] vs. response (three parameters)), n = 3 independent experiments for K3 and K6 and n = 5 for K37). c Immunoprecipitation of KRAS with <t>GST-RAF-RBD</t> is inhibited by the RAS-binding Affimers, K3, K6, and K37 compared to control Affimer (Variable regions of AAAA and AAE) which does not differ from the no Affimer (PBS). GST alone does not pull down RAS (Quantification using ImageQuantTL; n = 3 independent experiments). d A representative Western blot of the pull-down experiment from c . Data are mean ± SEM, One-way ANOVA with Dunnett’s post-hoc test * p = 0.0307 K6, p = 0.0439 K37, *** p = 0.0002 GST, **** p < 0.0001 K3. SOScat catalytic domain of SOS1 (Son of Sevenless). Con. Control Affimer, RBD RAS Binding Domain, IP immunoprecipitation, GST Glutathione-S-Transferase.
Anti P Raf 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/raf+1/p-Raf-1+Antibody/pmc09274493-169-35-38
Average 93 stars, based on 1 article reviews
anti p raf 1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


Figure 1. Crystal structure of DENV-NS5 (PDB ID: 4V0R) and crystal structure of DENV-NS5 RdRp domain in complex with Compound 27 (PDB ID: 5K5M).

Journal: Journal of enzyme inhibition and medicinal chemistry

Article Title: Identification of novel inhibitors of dengue viral NS5 RNA-dependent RNA polymerase through molecular docking, biological activity evaluation and molecular dynamics simulations.

doi: 10.1080/14756366.2025.2463006

Figure Lengend Snippet: Figure 1. Crystal structure of DENV-NS5 (PDB ID: 4V0R) and crystal structure of DENV-NS5 RdRp domain in complex with Compound 27 (PDB ID: 5K5M).

Article Snippet: Firstly, the docking protocol has been validated by redocking original ligand (Compound 27) of crystal structure of DeNV-Ns5 to its binding domain. the docked pose is in agreement with the original pose, and the RsMD value of the two is 0.346 Å (Figure s1). after systematic molecular docking process, 200 candidates were retained from the 1.6 million compounds in the chemDiv and targetMol (Usa) database. their performance was evaluated using three key metrics: docking score, Uni-score Rescore, and MM/GBsa binding free energy.

Techniques:

(A) A two-week growth CRISPR screen of 150 common Ras-proximal proteins in diploid primary human melanocytes (MC) and 5 MT Ras cell lines. Left heatmap negative selection FDR values (FDR ≤ 0.18) in each cell type by the MAGeCK algorithm (Li et al., 2014). The right heatmap relative enrichment MT vs WT Ras in mass spectrometry data for each Ras isoform; new proteins (red), known proteins (*). Ranked by combined FDR and log2(PSM MT/WT Ras) score. (B) Common Ras-proximal interacting protein-protein network based on candidates with ≥1 database interaction with another common interactor. Large squares are novel and small squares are known interactors. (C) PLA in MT NRAS MM415 melanoma cells with endogenous mTOR and Pan-Ras or Ras:GTP; interaction (red), nuclei (blue). Scale bar, 20 μm. (D) Quantification of PLA analysis in (C). n=8-10 fields/condition. (E) Western blot of HA co-immunoprecipitation of empty vector (EV), FLAG-HA-6xHIS tagged NRASWT or FHH: NRASQ61K with endogenous mTOR, p110α and Raf1 in wild-type RAS CHL-1 cells. (F) Quantification of HA co-IP experiments as in (E). Values are normalized to HA pulldown signal and relative to NRASWT signal, n= 6 (Wilcoxon Signed Rank Test). (G) PLA in genotyped human colorectal adenocarcinomas with endogenous Pan-Ras and mTOR. Scale bar, 20 μm. (H) Quantification of PLA analysis in (G). Each dot represents median signal per patient. n=5 patients/genotype group, ≥7 images analyzed per patient (Mann-Whitney U Test). (I) Microscale thermophoresis with labeled FHH:Raf1RBD (18.2nM) with a titration series of GDP or GTPγs-loaded Ras. The binding curve is negative as the MST signal of the complex is lower than that of Raf1RBD alone. MST-on time of 15s, n = 3 independent replicates. (J) Microscale thermophoresis with labeled FHH:mTORKinaseDomain and FHH:mTORHEAT (23.4nM) with a titration series of GDP or GTPγs-loaded Ras. MST-on time of 2.5s, n ≥ 3 independent replicates. MST is mean ± SD. All other data mean ± SEM; *p< 0.05. See also Figures S3 and S4, Tables S2–4.

Journal: Molecular cell

Article Title: The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2

doi: 10.1016/j.molcel.2018.12.001

Figure Lengend Snippet: (A) A two-week growth CRISPR screen of 150 common Ras-proximal proteins in diploid primary human melanocytes (MC) and 5 MT Ras cell lines. Left heatmap negative selection FDR values (FDR ≤ 0.18) in each cell type by the MAGeCK algorithm (Li et al., 2014). The right heatmap relative enrichment MT vs WT Ras in mass spectrometry data for each Ras isoform; new proteins (red), known proteins (*). Ranked by combined FDR and log2(PSM MT/WT Ras) score. (B) Common Ras-proximal interacting protein-protein network based on candidates with ≥1 database interaction with another common interactor. Large squares are novel and small squares are known interactors. (C) PLA in MT NRAS MM415 melanoma cells with endogenous mTOR and Pan-Ras or Ras:GTP; interaction (red), nuclei (blue). Scale bar, 20 μm. (D) Quantification of PLA analysis in (C). n=8-10 fields/condition. (E) Western blot of HA co-immunoprecipitation of empty vector (EV), FLAG-HA-6xHIS tagged NRASWT or FHH: NRASQ61K with endogenous mTOR, p110α and Raf1 in wild-type RAS CHL-1 cells. (F) Quantification of HA co-IP experiments as in (E). Values are normalized to HA pulldown signal and relative to NRASWT signal, n= 6 (Wilcoxon Signed Rank Test). (G) PLA in genotyped human colorectal adenocarcinomas with endogenous Pan-Ras and mTOR. Scale bar, 20 μm. (H) Quantification of PLA analysis in (G). Each dot represents median signal per patient. n=5 patients/genotype group, ≥7 images analyzed per patient (Mann-Whitney U Test). (I) Microscale thermophoresis with labeled FHH:Raf1RBD (18.2nM) with a titration series of GDP or GTPγs-loaded Ras. The binding curve is negative as the MST signal of the complex is lower than that of Raf1RBD alone. MST-on time of 15s, n = 3 independent replicates. (J) Microscale thermophoresis with labeled FHH:mTORKinaseDomain and FHH:mTORHEAT (23.4nM) with a titration series of GDP or GTPγs-loaded Ras. MST-on time of 2.5s, n ≥ 3 independent replicates. MST is mean ± SD. All other data mean ± SEM; *p< 0.05. See also Figures S3 and S4, Tables S2–4.

Article Snippet: RAF1 Human Recombinant Protein , Origene , Cat# TP301983.

Techniques: CRISPR, Selection, Mass Spectrometry, Western Blot, Immunoprecipitation, Plasmid Preparation, Co-Immunoprecipitation Assay, MANN-WHITNEY, Microscale Thermophoresis, Labeling, Titration, Binding Assay

(A) BioID-western blot showing mTOR protein levels in the streptavidin pulldowns of birA*:NRASQ61K with shGFP, shRPTOR, shRICTOR or shMAPKAP1 with two independent hairpins in CHL-1 cells. PI3K p110α subunit, Raf1, and HA protein levels in streptavidin pulldowns are controls. Pulldown and input normalized values relative to the control shown below. (B) Quantification of mTOR, p110α and Raf1 protein levels in the streptavidin pulldown Normalized to HA pulldown and respective input levels and relative to shGFP mean, n=5 (unpaired two-sided t-test). (C) Quantification of protein remaining after knockdown compared to the average of controls for (B). (D) PLA in MT NRAS MM415 melanoma cells with endogenous Ras and mTOR with control, mTORC1 or mTORC2 component knockdown. Scale bar, 20 μm. (E) Quantification of PLA shown in (D). n=2 independent hairpins per knockdown. Relative to the mean of control knockdowns. (unpaired two-sided t-test). (F) Quantification of protein remaining after knockdown relative to mean signal of control knockdowns for PLA in (E). (G) Western blot of HA co-immunoprecipitation of empty vector (EV), FHH:NRASWT or FHH:NRASQ61K with endogenous Rictor, MAPKAP1 and Raptor in wild-type Ras CHL-1 cells. (H) Quantification of HA co-IP experiments as in (G). Values normalized to HA pulldown signal and relative to NRASWT signal. n= 5 or 8 (Welch’s two-sided t-test). (I) Western blot showing mTOR protein levels in the input and streptavidin pulldowns of birA* control, NRASWT, NRASQ61K and NRASQ61K Effector Domain Alanine point mutants. (*) non-specific background band. (J) Quantification of streptavidin pulldown protein levels as in (I). mTOR signal normalized to HA signal. All values relative to birA*: NRASQ61K, n=3 (Welch’s two-sided t-test relative to Q61K). All graphed data are mean ± SEM. *p< 0.05, **p< 0.01, ***p< 0.001, ****p< 0.0001, ns= not significant. See also Figure S5.

Journal: Molecular cell

Article Title: The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2

doi: 10.1016/j.molcel.2018.12.001

Figure Lengend Snippet: (A) BioID-western blot showing mTOR protein levels in the streptavidin pulldowns of birA*:NRASQ61K with shGFP, shRPTOR, shRICTOR or shMAPKAP1 with two independent hairpins in CHL-1 cells. PI3K p110α subunit, Raf1, and HA protein levels in streptavidin pulldowns are controls. Pulldown and input normalized values relative to the control shown below. (B) Quantification of mTOR, p110α and Raf1 protein levels in the streptavidin pulldown Normalized to HA pulldown and respective input levels and relative to shGFP mean, n=5 (unpaired two-sided t-test). (C) Quantification of protein remaining after knockdown compared to the average of controls for (B). (D) PLA in MT NRAS MM415 melanoma cells with endogenous Ras and mTOR with control, mTORC1 or mTORC2 component knockdown. Scale bar, 20 μm. (E) Quantification of PLA shown in (D). n=2 independent hairpins per knockdown. Relative to the mean of control knockdowns. (unpaired two-sided t-test). (F) Quantification of protein remaining after knockdown relative to mean signal of control knockdowns for PLA in (E). (G) Western blot of HA co-immunoprecipitation of empty vector (EV), FHH:NRASWT or FHH:NRASQ61K with endogenous Rictor, MAPKAP1 and Raptor in wild-type Ras CHL-1 cells. (H) Quantification of HA co-IP experiments as in (G). Values normalized to HA pulldown signal and relative to NRASWT signal. n= 5 or 8 (Welch’s two-sided t-test). (I) Western blot showing mTOR protein levels in the input and streptavidin pulldowns of birA* control, NRASWT, NRASQ61K and NRASQ61K Effector Domain Alanine point mutants. (*) non-specific background band. (J) Quantification of streptavidin pulldown protein levels as in (I). mTOR signal normalized to HA signal. All values relative to birA*: NRASQ61K, n=3 (Welch’s two-sided t-test relative to Q61K). All graphed data are mean ± SEM. *p< 0.05, **p< 0.01, ***p< 0.001, ****p< 0.0001, ns= not significant. See also Figure S5.

Article Snippet: RAF1 Human Recombinant Protein , Origene , Cat# TP301983.

Techniques: Western Blot, Control, Knockdown, Immunoprecipitation, Plasmid Preparation, Co-Immunoprecipitation Assay

KEY RESOURCES TABLE

Journal: Molecular cell

Article Title: The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2

doi: 10.1016/j.molcel.2018.12.001

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: RAF1 Human Recombinant Protein , Origene , Cat# TP301983.

Techniques: Western Blot, Transduction, In Situ, Virus, Recombinant, Lysis, Protease Inhibitor, Staining, Magnetic Beads, Cloning, Bicinchoninic Acid Protein Assay, Isolation, Labeling, Viability Assay, RNA Sequencing, Sequencing, Gene Expression, CRISPR, Mass Spectrometry, Expressing, Mutagenesis, shRNA, Plasmid Preparation, Control, Luciferase, Software, Membrane, Blocking Assay

a Nucleotide exchange assay shows 3 Affimers, K3 (green triangles), K6 (turquoise triangles), and K37 (yellow triangles), inhibit SOS1-mediated nucleotide exchange, whilst K19 (orange diamonds) and K68 (magenta triangles) show inhibition of intrinsic nucleotide exchange and K69 (purple hexagons) and K91 (navy stars) do not inhibit nucleotide exchange at 10 µM. KRAS alone is shown as black squares and in the presence of SOS1 cat as red circles. b Affimers K3, K6, and K37 demonstrate dose-response inhibition of KRAS WT nucleotide exchange (Data fitted to the Hill Model ([Affimer] vs. response (three parameters)), n = 3 independent experiments for K3 and K6 and n = 5 for K37). c Immunoprecipitation of KRAS with GST-RAF-RBD is inhibited by the RAS-binding Affimers, K3, K6, and K37 compared to control Affimer (Variable regions of AAAA and AAE) which does not differ from the no Affimer (PBS). GST alone does not pull down RAS (Quantification using ImageQuantTL; n = 3 independent experiments). d A representative Western blot of the pull-down experiment from c . Data are mean ± SEM, One-way ANOVA with Dunnett’s post-hoc test * p = 0.0307 K6, p = 0.0439 K37, *** p = 0.0002 GST, **** p < 0.0001 K3. SOScat catalytic domain of SOS1 (Son of Sevenless). Con. Control Affimer, RBD RAS Binding Domain, IP immunoprecipitation, GST Glutathione-S-Transferase.

Journal: Nature Communications

Article Title: RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site

doi: 10.1038/s41467-021-24316-0

Figure Lengend Snippet: a Nucleotide exchange assay shows 3 Affimers, K3 (green triangles), K6 (turquoise triangles), and K37 (yellow triangles), inhibit SOS1-mediated nucleotide exchange, whilst K19 (orange diamonds) and K68 (magenta triangles) show inhibition of intrinsic nucleotide exchange and K69 (purple hexagons) and K91 (navy stars) do not inhibit nucleotide exchange at 10 µM. KRAS alone is shown as black squares and in the presence of SOS1 cat as red circles. b Affimers K3, K6, and K37 demonstrate dose-response inhibition of KRAS WT nucleotide exchange (Data fitted to the Hill Model ([Affimer] vs. response (three parameters)), n = 3 independent experiments for K3 and K6 and n = 5 for K37). c Immunoprecipitation of KRAS with GST-RAF-RBD is inhibited by the RAS-binding Affimers, K3, K6, and K37 compared to control Affimer (Variable regions of AAAA and AAE) which does not differ from the no Affimer (PBS). GST alone does not pull down RAS (Quantification using ImageQuantTL; n = 3 independent experiments). d A representative Western blot of the pull-down experiment from c . Data are mean ± SEM, One-way ANOVA with Dunnett’s post-hoc test * p = 0.0307 K6, p = 0.0439 K37, *** p = 0.0002 GST, **** p < 0.0001 K3. SOScat catalytic domain of SOS1 (Son of Sevenless). Con. Control Affimer, RBD RAS Binding Domain, IP immunoprecipitation, GST Glutathione-S-Transferase.

Article Snippet: GST-thr-RAF1-RBD was provided as a gift from Dominic Esposito (Addgene plasmid # 86033) and produced as previously described .

Techniques: Inhibition, Immunoprecipitation, Binding Assay, Western Blot